Key result
Quantifying absolute myocardial blood flow via PET, SPECT, CMR, and CT improves CAD diagnosis and prognosis.
Why the study?
Recent trials shifted focus toward CCTA over functional testing, but advances enabling absolute quantification of myocardial blood flow across PET, CMR, and CT underscore the need to reappraise myocardial perfusion imaging.
Advances in PET, CMR, and CT enable absolute quantification of myocardial blood flow, improving diagnostic and prognostic performance in patients with known or suspected CAD and other conditions.
May support absolute myocardial blood flow quantification in CAD; leaves open prospective outcome validation across modalities.
Recent clinical trials demonstrating the prognostic value of coronary computed tomography angiography (CCTA), and the limited incremental prognostic benefit of ischemia-guided revascularization over optimal medical therapy, have shifted focus away from functional testing. Nevertheless, myocardial perfusion assessment remains essential in patients with known or suspected coronary artery disease (CAD), microvascular dysfunction, ischemia with normal coronary arteries (INOCA), coronary anomalies, and cardiomyopathies. Advances in positron emission tomography (PET), cardiovascular magnetic resonance (CMR), and computed tomography (CT) now enable absolute quantification of myocardial blood flow (MBF), providing improved diagnostic and prognostic performance and underscoring the need to reappraise myocardial perfusion imaging. This mini-review summarizes key physiological principles, contemporary acquisition and post-processing strategies, and the clinical relevance of myocardial perfusion imaging (MPI) across PET, Single Photon Emission Computed Tomography (SPECT), CMR, and CT, and discusses future perspectives in quantitative MPI.
No takes yet. Share an insight, caveat, or question.
Kato et al. (2026) conducted a review in Coronary artery disease. Quantitative myocardial perfusion imaging (PET, SPECT, CMR, CT) was evaluated. Advances in PET, SPECT, CMR, and CT enable absolute quantification of myocardial blood flow, providing improved diagnostic and prognostic performance in coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: